Browsing by Author Goldhirsch, A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 17 of 17
Issue DateTitleAuthor(s)Citation
2016Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT TrialsCoates, Alan; Colleoni, Marco; Fleming, Gini; Francis, Prudence; Gelber, Richard; Goldhirsch, A; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Pinotti, Graziella; Price, Karen N; Regan, Meredith; Tondini, Carlo; Viale, Giuseppe; Walley, Barbara; School of Public Health: Public HealthAbsolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT Trials, Journal of Clinical Oncology, vol.34, 19, 2016,pp 2221-2230
2008Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trialCoates, Alan; Altermatt, Hans J; Braye, Stephen; Castiglione-Gertsch, Monica; Del Curto, Barbara; Dell'Orto, Patrizia; Gelber, Richard D. (Prof); Goldhirsch, A; Gusterson, Barry; Henriksen, Katrine L; Lacroix-Triki, Magali; Lykkesfeldt, Anne E; Mastropasqua, Mauro G.; Mery, Eliane; Price, K. N.; Rasmussen, Brigitte B; Regan, Meredith M.; Thurlimann, Beat; Viale, Giuseppe; School of Public Health: Public HealthAdjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial, The Lancet, vol.9, N/A, 2008,pp 23-28
2010Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancerCoates, Alan; Cole, Bernard; Crivellari, Diana; Gelber, Richard; Gelber, Shari; Goldhirsch, A; Holmberg, Stig B.; Paridaens, Robert; Price, Karen N.; Thurlimann, B.; School of Public Health: Public HealthAdjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer, Breast Cancer Research and Treatment, vol.123, 1,pp 303-310
2010Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialCoates, Alan; Bernhard, Jurg; Cardoso, Fatima; Gelber, Richard D. (Prof); Goldhirsch, A; Harvey, V; Pagani, O.; Phillips, Kelly-Anne; Price, Karen; Ribi, Karen; Stephens, Alisa; Sun, Zhuoxin; Thompson, Alastair; Thurlimann, B.; School of Public Health: Public HealthCognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial, The Breast, vol.19, 5,pp 388-395
2017Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFTCoates, Alan; Abdi, Ehtesham; Colleoni, Marco; Fleming, G. F.; Francis, P A; Gelber, Richard; Goldhirsch, A; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Parmar, Vani; Pinotti, Graziella; Regan, Meredith M.; Ruhstaller, Thomas; Salim, Muhammad; Spazzapan, Simon; Tondini, Carlo; Walley, B. A.; NH&MRC Clinical Trials CentreConcurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFT, Annals of Oncology, vol.28, 9, 2017,pp 2225-2232
2011Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX.Coates, Alan; Aebi, S; Braun, D; Castiglione-Gertsch, M; Crivellari, Diana; Gelber, Richard; Goldhirsch, A; Gusterson, B. A.; Karlsson, P; Lindtner, Jurii; Price, K. N.; Rabaglio, Manuela; Regan, Meredith M.; Simoncini, Edda; Snyder, Raymond; Sun, Z; Viale, Giuseppe; School of Public Health: Public HealthDifferential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX., Annals of Oncology, vol.22, 9, 2011,pp 1981-1987
2008Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancerCoates, Alan; Castiglione-Gertsch, Monica; Cole, B F; Collins, John; Crivellari, Diana; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, A; Golouh, Rastko; Gruber, G; Gusterson, Barry; Holmberg, Stig B.; Lindtner, Jurii; Price, K. N.; Simoncini, Edda; Thurlimann, Beat; School of Public Health: Public HealthExtracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer, Annals of Oncology, vol.19, N/A, 2008,pp 1393-1401
2012Is Adjuvant Chemotherapy Useful for Women With Luminal A Breast Cancer?Coates, Alan; Colleoni, Marco; Goldhirsch, A; School of Public Health: Public HealthIs Adjuvant Chemotherapy Useful for Women With Luminal A Breast Cancer?, Journal of Clinical Oncology, vol.30, 12, 2012,pp 1260-1263
2013Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node-Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IXCoates, Alan; Cardoso, Fatima; Castiglione-Gertsch, Monica; Crivellari, Diana; Gelber, Richard D. (Prof); Goldhirsch, A; Metzger-Filho, Otto; Price, Karen N; Snyder, Raymond; Viale, Giuseppe; Zhuoxin, Sun; School of Public Health: Public HealthPatterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node-Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX, Journal of Clinical Oncology, vol.31, 25, 2013,pp 3083-3091
2013Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Coates, Alan; Gelber, RD; Goldhirsch, A; Piccart-Gebhart, Martine J (Prof); Senn, H.-J.; Thurlimann, B.; Winer, EP; School of Public Health: Public HealthPersonalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013, Annals of Oncology, vol.24, 9, 2013,pp 2206-2223
2010Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapyCoates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Goldhirsch, A; Maiorano, Eugenio; Mastropasqua, Mauro G.; Price, Karen; Regan, Meredith M.; Viale, Giuseppe; School of Public Health: Public HealthPrognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy, Breast Cancer Research and Treatment, vol.121, 1,pp 211-218
2005Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index.Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Goldhirsch, A; Li, Sigui; Price, K. N.; School of Public Health: Public HealthRelation between chemotherapy dose, oestrogen receptor expression, and body-mass index., The Lancet, vol.366,(9491),2005,pp 1108-1110
2003Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VIICoates, Alan; Bonetti, M; Castiglione-Gertsch, Monica; et, al; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, A; Holmberg, Stig B.; Lindtner, Jurij; Thurlimann, B.; Wallgren, A; School of Public Health: Public HealthRisk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII, Journal of Clinical Oncology, vol.21,(7),2003,pp 1205-1213
2009Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.Coates, Alan; Castiglione-Gertsch, Monica; Fantini, Manuela; Gelber, Richard D. (Prof); Gelber, Shari; Gianni, Lorenzo; Goldhirsch, A; Pagani, O.; Panzini, Ilaria; Price, Karen N.; Ravaioli, Alberto; Simoncini, Edda; School of Public Health: Public HealthSecond non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group., European Journal of Cancer, vol.45, 4,pp 561-571
2012Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancerCoates, Alan; Aldridge, Julie; Bernhard, J; Cardoso, Fatima; Gelber, Richard D. (Prof); Goldhirsch, A; Harvey, V; Pagani, Olivia; Phillips, Kelly-Anne; Price, Karen N.; Ribi, Karin; Thompson, Alastair; Thurlimann, Beat; School of Public Health: Public HealthSubjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer, British Journal of Cancer, vol.106, 10, 2012,pp 1618-1625
2003Tailoring adjuvant treatment for the individual breast cancer patientCoates, Alan; Bonetti, M; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Goldhirsch, A; School of Public Health: Public HealthTailoring adjuvant treatment for the individual breast cancer patient, Breast, vol.12,(6),2003,pp 558-568
2015Tailoring therapies - improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Coates, Alan; Gelber, Richard D; Gnant, Michael; Goldhirsch, A; Piccart-Gebhart, Martine J (Prof); Senn, H-J; Thurlimann, B.; Winer, EP; School of Public Health: Public HealthTailoring therapies - improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015, Annals of Oncology, vol.26, 8, 2015,pp 1533-1546